Cargando…
Insulin-Degrading Enzyme, an Under-Estimated Potential Target to Treat Cancer?
Insulin-degrading enzyme (IDE) is a multifunctional protease due to the variety of its substrates, its various cellular locations, its conservation between species and its many non-proteolytic functions. Numerous studies have successfully demonstrated its implication in two main therapeutic areas: m...
Autores principales: | Lesire, Laetitia, Leroux, Florence, Deprez-Poulain, Rebecca, Deprez, Benoit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998118/ https://www.ncbi.nlm.nih.gov/pubmed/35406791 http://dx.doi.org/10.3390/cells11071228 |
Ejemplares similares
-
Ensemble cryoEM elucidates the mechanism of insulin capture and degradation by human insulin degrading enzyme
por: Zhang, Zhening, et al.
Publicado: (2018) -
Molecular Design in Practice: A Review of Selected Projects in a French Research Institute That Illustrates the Link between Chemical Biology and Medicinal Chemistry
por: Deprez, Benoit, et al.
Publicado: (2021) -
Catalytic site inhibition of insulin-degrading enzyme by a small molecule induces glucose intolerance in mice
por: Deprez-Poulain, Rebecca, et al.
Publicado: (2015) -
Discovery of the First Selective Nanomolar Inhibitors of ERAP2 by Kinetic Target‐Guided Synthesis
por: Camberlein, Virgyl, et al.
Publicado: (2022) -
Targeting Insulin-Degrading Enzyme in Insulin Clearance
por: Leissring, Malcolm A., et al.
Publicado: (2021)